Læknablaðið - 15.08.1984, Blaðsíða 38

200
LÆK.NABLADIÐ
23) LeClerq G, Heuson JC. Quantitative aspects of
estrogen receptors in relation to therapeutic
response. In: Steroid Receptors and the Mana-
gement of Cancer (Ed.) Thompson EB, Lipp-
mann ME. Boca Raton: CRC Press 1979; 41-56.
24) Saez S, Martin PM, Chouvet CD. Estradiol and
progesterone receptor levels in human breast
adenocarcinoma in relation to plasma estrogen
and progesterone levels. Cancer Res 1978; 38:
3468-73.
25) Toft DO, O’Malley BW. Target tissue receptors
for progesterone: the influence of estrogen.
Endocrinol 1972; 90: 1041-5.
26) McGuire WL, Horwitz KB. A role for proge-
sterone in breast cancer. Ann NY Acad Sci
1977;286:90-100.
27) Gunnlaugur Geirsson, Krabbameinsfélag ís-
lands, Suðurgötu 22-24 Reykjavík, ísland.
Munnleg heimild.
28) Hasson J, Luhan PA, Kohl MW. Comparison of
estrogen receptor levels in breast cancer sam-
ples from mastectomy and frozen section speci-
mens. Cancer 1981; 47: 138-9.
29) Meyer JS, Schectman K, Valdes R. Estrogen
and progesterone receptor assays on breast
carcinoma from mastectomy specimens. Cancer
1983;52:2139-43.